Literature DB >> 35122210

A review of the safety and efficacy of current COVID-19 vaccines.

Zehong Huang1, Yingying Su1, Tianying Zhang1, Ningshao Xia2.   

Abstract

Vaccination is the most effective and feasible way to contain the Coronavirus disease 2019 (COVID-19) pandemic. The rapid development of effective COVID-19 vaccines is an extraordinary achievement. This study reviewed the efficacy/effectiveness, immunogenicity, and safety profile of the 12 most progressed COVID-19 vaccines and discussed the challenges and prospects of the vaccine-based approaches in a global crisis. Overall, most of the current vaccines have shown safety and efficacy/effectiveness during actual clinical trials or in the real-world studies, indicating a development of pandemic control. However, many challenges are faced by pandemic control in terms of maximizing the effect of vaccines, such as rapid vaccine coverage, strategies to address variants with immune escape capability, and surveillance of vaccine safety in the medium- and long-terms.
© 2022. Higher Education Press.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; effectiveness; efficacy; immunogenicity; safety; vaccine

Mesh:

Substances:

Year:  2022        PMID: 35122210      PMCID: PMC8815389          DOI: 10.1007/s11684-021-0893-y

Source DB:  PubMed          Journal:  Front Med        ISSN: 2095-0217            Impact factor:   9.927


  74 in total

1.  Placebo-Controlled Trials of Covid-19 Vaccines - Why We Still Need Them.

Authors:  Philip R Krause; Thomas R Fleming; Ira M Longini; Richard Peto; Valerie Beral; Balram Bhargava; Alejandro Cravioto; Jakob P Cramer; Susan S Ellenberg; J Peter Figueroa; Elizabeth Halloran; Ana M Henao-Restrepo; Michael J Ryan; Myron M Levine; Martha Nason; Hanna M Nohynek; Stanley Plotkin; Helen Rees; Jerome A Singh; Soumya Swaminathan
Journal:  N Engl J Med       Date:  2020-12-02       Impact factor: 91.245

2.  [Evaluation of safety of two inactivated COVID-19 vaccines in a large-scale emergency use].

Authors:  Z N Yang; Y Y Zhao; L Li; H D Gao; Q Cai; X X Sun; F S Zhang; J F Su; Y N Zhang; X Shu; X W Wang; Y K Yang; Y T Zhang; S Zhou; X M Yang
Journal:  Zhonghua Liu Xing Bing Xue Za Zhi       Date:  2021-06-10

3.  SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity.

Authors:  Chihiro Motozono; Mako Toyoda; Jiri Zahradnik; Akatsuki Saito; Hesham Nasser; Toong Seng Tan; Isaac Ngare; Izumi Kimura; Keiya Uriu; Yusuke Kosugi; Yuan Yue; Ryo Shimizu; Jumpei Ito; Shiho Torii; Akiko Yonekawa; Nobuyuki Shimono; Yoji Nagasaki; Rumi Minami; Takashi Toya; Noritaka Sekiya; Takasuke Fukuhara; Yoshiharu Matsuura; Gideon Schreiber; Terumasa Ikeda; So Nakagawa; Takamasa Ueno; Kei Sato
Journal:  Cell Host Microbe       Date:  2021-06-15       Impact factor: 21.023

4.  Anaphylactic reactions to novel mRNA SARS-CoV-2/COVID-19 vaccines.

Authors:  John M Kelso
Journal:  Vaccine       Date:  2021-01-06       Impact factor: 3.641

5.  Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.

Authors:  Lindsey R Baden; Hana M El Sahly; Brandon Essink; Karen Kotloff; Sharon Frey; Rick Novak; David Diemert; Stephen A Spector; Nadine Rouphael; C Buddy Creech; John McGettigan; Shishir Khetan; Nathan Segall; Joel Solis; Adam Brosz; Carlos Fierro; Howard Schwartz; Kathleen Neuzil; Larry Corey; Peter Gilbert; Holly Janes; Dean Follmann; Mary Marovich; John Mascola; Laura Polakowski; Julie Ledgerwood; Barney S Graham; Hamilton Bennett; Rolando Pajon; Conor Knightly; Brett Leav; Weiping Deng; Honghong Zhou; Shu Han; Melanie Ivarsson; Jacqueline Miller; Tal Zaks
Journal:  N Engl J Med       Date:  2020-12-30       Impact factor: 91.245

6.  Susceptibility of Circulating SARS-CoV-2 Variants to Neutralization.

Authors:  Guo-Lin Wang; Zhuang-Ye Wang; Li-Jun Duan; Qing-Chuan Meng; Ming-Dong Jiang; Jing Cao; Lin Yao; Ka-Li Zhu; Wu-Chun Cao; Mai-Juan Ma
Journal:  N Engl J Med       Date:  2021-04-06       Impact factor: 91.245

7.  Antibody evasion by the P.1 strain of SARS-CoV-2.

Authors:  Wanwisa Dejnirattisai; Daming Zhou; Piyada Supasa; Chang Liu; Alexander J Mentzer; Helen M Ginn; Yuguang Zhao; Helen M E Duyvesteyn; Aekkachai Tuekprakhon; Rungtiwa Nutalai; Beibei Wang; César López-Camacho; Jose Slon-Campos; Thomas S Walter; Donal Skelly; Sue Ann Costa Clemens; Felipe Gomes Naveca; Valdinete Nascimento; Fernanda Nascimento; Cristiano Fernandes da Costa; Paola Cristina Resende; Alex Pauvolid-Correa; Marilda M Siqueira; Christina Dold; Robert Levin; Tao Dong; Andrew J Pollard; Julian C Knight; Derrick Crook; Teresa Lambe; Elizabeth Clutterbuck; Sagida Bibi; Amy Flaxman; Mustapha Bittaye; Sandra Belij-Rammerstorfer; Sarah C Gilbert; Miles W Carroll; Paul Klenerman; Eleanor Barnes; Susanna J Dunachie; Neil G Paterson; Mark A Williams; David R Hall; Ruben J G Hulswit; Thomas A Bowden; Elizabeth E Fry; Juthathip Mongkolsapaya; Jingshan Ren; David I Stuart; Gavin R Screaton
Journal:  Cell       Date:  2021-03-30       Impact factor: 41.582

8.  BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting.

Authors:  Noa Dagan; Noam Barda; Eldad Kepten; Oren Miron; Shay Perchik; Mark A Katz; Miguel A Hernán; Marc Lipsitch; Ben Reis; Ran D Balicer
Journal:  N Engl J Med       Date:  2021-02-24       Impact factor: 91.245

9.  Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.

Authors:  Mark G Thompson; Jefferey L Burgess; Allison L Naleway; Harmony Tyner; Sarang K Yoon; Jennifer Meece; Lauren E W Olsho; Alberto J Caban-Martinez; Ashley L Fowlkes; Karen Lutrick; Holly C Groom; Kayan Dunnigan; Marilyn J Odean; Kurt Hegmann; Elisha Stefanski; Laura J Edwards; Natasha Schaefer-Solle; Lauren Grant; Katherine Ellingson; Jennifer L Kuntz; Tnelda Zunie; Matthew S Thiese; Lynn Ivacic; Meredith G Wesley; Julie Mayo Lamberte; Xiaoxiao Sun; Michael E Smith; Andrew L Phillips; Kimberly D Groover; Young M Yoo; Joseph Gerald; Rachel T Brown; Meghan K Herring; Gregory Joseph; Shawn Beitel; Tyler C Morrill; Josephine Mak; Patrick Rivers; Brandon P Poe; Brian Lynch; Yingtao Zhou; Jing Zhang; Anna Kelleher; Yan Li; Monica Dickerson; Erika Hanson; Kyley Guenther; Suxiang Tong; Allen Bateman; Erik Reisdorf; John Barnes; Eduardo Azziz-Baumgartner; Danielle R Hunt; Melissa L Arvay; Preeta Kutty; Alicia M Fry; Manjusha Gaglani
Journal:  N Engl J Med       Date:  2021-06-30       Impact factor: 91.245

10.  Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices - United States, June 2021.

Authors:  Julia W Gargano; Megan Wallace; Stephen C Hadler; Gayle Langley; John R Su; Matthew E Oster; Karen R Broder; Julianne Gee; Eric Weintraub; Tom Shimabukuro; Heather M Scobie; Danielle Moulia; Lauri E Markowitz; Melinda Wharton; Veronica V McNally; José R Romero; H Keipp Talbot; Grace M Lee; Matthew F Daley; Sara E Oliver
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2021-07-09       Impact factor: 17.586

View more
  5 in total

1.  COVID-19 Vaccine-Induced Cerebral Sinus Thrombosis: Coincidence vs. Cause?

Authors:  Abdalla Fadul; ELMustafa Abdalla; Elabbass Abdelmahmuod; Mohammed Abdulgayoom; Elrazi Ali; Akram Al-Warqi; Hani Al-Yahary
Journal:  Cureus       Date:  2022-06-29

2.  A Unique Robust Dual-Promoter-Driven and Dual-Reporter-Expressing SARS-CoV-2 Replicon: Construction and Characterization.

Authors:  Ying Liu; Lu Li; Khalid A Timani; Johnny J He
Journal:  Viruses       Date:  2022-05-05       Impact factor: 5.818

3.  No Differences in Wound Healing and Scar Formation Were Observed in Patients With Different COVID-19 Vaccination Intervals.

Authors:  Chen Dong; Zhou Yu; Xin Quan; Siming Wei; Jiayang Wang; Xianjie Ma
Journal:  Front Public Health       Date:  2022-06-01

Review 4.  The Importance of Vaccination in the Context of the COVID-19 Pandemic: A Brief Update Regarding the Use of Vaccines.

Authors:  Bruna Aparecida Souza Machado; Katharine Valéria Saraiva Hodel; Larissa Moraes Dos Santos Fonseca; Vinícius Couto Pires; Luis Alberto Brêda Mascarenhas; Leone Peter Correia da Silva Andrade; Marcelo Albano Moret; Roberto Badaró
Journal:  Vaccines (Basel)       Date:  2022-04-12

5.  Social expectations and government incentives in Malaysia's COVID-19 vaccine uptake.

Authors:  N Izzatina Abdul Aziz; Sam Flanders; Melati Nungsari
Journal:  PLoS One       Date:  2022-09-26       Impact factor: 3.752

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.